|
Published by: Global Markets Direct
Published: Dec. 26, 2012 - 38 Pages
Table of Contents- Introduction
- Global Markets Direct Report Coverage
- Food Allergy Overview
- Therapeutics Development
- An Overview of Pipeline Products for Food Allergy
- Food Allergy Therapeutics under Development by Companies
- Food Allergy Therapeutics under Investigation by Universities/Institutes
- Mid Clinical Stage Products
- Comparative Analysis
- Early Clinical Stage Products
- Comparative Analysis
- Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Food Allergy Therapeutics – Products under Development by Companies
- Food Allergy Therapeutics – Products under Investigation by Universities/Institutes
- Companies Involved in Food Allergy Therapeutics Development
- Novartis AG
- DBV Technologies
- Selecta Biosciences, Inc.
- Biomay AG
- Food Allergy – Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Drug Profiles
- omalizumab - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- omalizumab - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- Trichuris Suis Ova - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- Fish Allergen Hypoallergenic Vaccine - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- QGE-031 - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- GE-2 - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- Allergen Vaccine Program - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- t2SVP For Food Allergy - Drug Profile
- Product Description
- Mechanism of Action
- R&D Progress
- Food Allergy Therapeutics – Drug Profile Updates
- Appendix
- Methodology
- Coverage
- Secondary Research
- Primary Research
- Expert Panel Validation
- Contact Us
- Disclaimer
- List of Tables
- Number of Products Under Development for Food Allergy, H2 2012
- Products under Development for Food Allergy – Comparative Analysis, H2 2012
- Number of Products under Development by Companies, H2 2012
- Number of Products under Investigation by Universities/Institutes, H2 2012
- Comparative Analysis by Mid Clinical Stage Development, H2 2012
- Comparative Analysis by Early Clinical Stage Development, H2 2012
- Comparative Analysis by Discovery and Pre-Clinical Stage Development, H2 2012
- Products under Development by Companies, H2 2012
- Products under Investigation by Universities/Institutes, H2 2012
- Novartis AG, H2 2012
- DBV Technologies, H2 2012
- Selecta Biosciences, Inc., H2 2012
- Biomay AG, H2 2012
- Assessment by Monotherapy Products, H2 2012
- Assessment by Stage and Route of Administration, H2 2012
- Assessment by Stage and Molecule Type, H2 2012
- Food Allergy Therapeutics – Drug Profile Updates
- List of Figures
- Number of Products under Development for Food Allergy, H2 2012
- Products under Development for Food Allergy – Comparative Analysis, H2 2012
- Products under Development by Companies, H2 2012
- Products under Investigation by Universities/Institutes, H2 2012
- Mid Clinical Stage Products, H2 2012
- Early Clinical Stage Products, H2 2012
- Discovery and Pre-Clinical Stage Products, H2 2012
- Assessment by Monotherapy Products, H2 2012
- Assessment by Route of Administration, H2 2012
- Assessment by Stage and Route of Administration, H2 2012
- Assessment by Molecule Type, H2 2012
- Assessment by Stage and Molecule Type, H2 2012
AbstractFood Allergy – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, 'Food Allergy - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Food Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Food Allergy. Food Allergy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope- A snapshot of the global therapeutic scenario for Food Allergy.
- A review of the Food Allergy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Food Allergy pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy- Identify and understand important and diverse types of therapeutics under development for Food Allergy.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Food Allergy pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
Get full details about this report >>
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports,
company profiles and country profiles from over 720 research firms. Our reports will
provide you with the critical business and competitive intelligence you need for strategic planning and marketing
research. Coverage includes the US, UK, Europe, Asia and global markets.
|
